A novel psychiatric scale developed by colleagues of Gedeon Richter Plc. in collaboration with academia was also presented at the 37 ECNP conference BUDAPEST, Hungary, Sept. 25, 2024 /PRNewswire ...

AbbVie (NYSE: ABBV) and Gedeon Richter Plc. ('Richter') today announced a new discovery, co-development and license agreement to advance novel targets for the potential treatment of ...

AbbVie has entered a collaboration with Hungary-based pharmaceutical company Gedeon Richter to develop new treatments for neuropsychiatric conditions. The agreement focuses on discovering, co ...

Gedeon Richter announces proposed combination with Polpharma for shares, valuing Polpharma at HUF 231 billion (US$1,337 million). Building pharmaceutical leadership in Central Eastern Europe (CEE) ...

Gedeon Richter, (www.richter.hu) headquartered in Budapest/Hungary, is a major pharmaceutical company in Hungary and one of the largest in Central Eastern Europe, with consolidated sales of ...

London, United Kingdom, Wednesday 03 November 2021 – Gedeon Richter UK Ltd. (“Gedeon Richter”) today announced that the Medicines and Healthcare Products Regulatory Agency (MHRA) has granted a UK ...

Mithra and Gedeon Richter Sign Supply Agreement for Production of API for Estelle ® and Donesta ® Liege, Belgium and Budapest, Hungary 8 August 2023 – 07:30 CEST – Mithra (Euronext Brussels ...

They worked together before on bipolar medication Vraylar, and now Allergan—ahem, AbbVie—will try to repeat that success with Gedeon Richter.

Gedeon Richter Nyrt., eastern Europe’s biggest pharmaceutical company that’s battled investor concerns this year over one of its flagship drugs, surged after four days of losses as Chief ...

TEL AVIV (MarketWatch) -- Forest Laboratories Inc. FRX, +2.17% and Gedeon Richter PLC said Monday that in a Phase II study of cariprazine, a potential treatment for bipolar depression, the overall ...